NCT04555941View on ClinicalTrials.gov

The Effects of Intermittent Theta Burst Stimulation in MCI and Early AD

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

October 5, 2020

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
Mild Cognitive ImpairmentAlzheimer DiseaseCognitive Decline
Interventions
DEVICE

intermittent theta burst stimulation

active or Sham iTBS will be given to the AD/MCI patient

Trial Locations (1)

Unknown

Shuang Ho Hospital, New Taipei City

All Listed Sponsors
lead

Taipei Medical University Shuang Ho Hospital

OTHER

NCT04555941 - The Effects of Intermittent Theta Burst Stimulation in MCI and Early AD | Biotech Hunter | Biotech Hunter